Vitamin D’s Heart Prevention Win; ATTR Depleter Does So-So; Gene Therapy Trial Hold

(MedPage Today) — Personalized vitamin D supplementation — often requiring 5,000 IU of vitamin D each day — did prove to have secondary prevention benefits in the TARGET-D randomized trial presented at the American Heart Association meeting…